SOURCE: Press and Public Affairs Bureau
As the numbers of COVID-19 infections continue to rise, we urge the Department of Health and the Food and Drug Administration to promptly inform the public of their options in terms of prevention and treatment against this deadly virus.
With coronavirus cases surging and more people dying, regulators should find it necessary to look into the safety and efficacy of Ivermectin and other repurposed drugs for COVID-19.
People have become desperate for a cure. Fast-tracking clinical trials and processes to either grant Ivermectin an emergency use authority or conclusively declaring it unsafe will put the matter to rest.
These are desperate times that call for a more proactive regulatory approach. People need alternative remedies to prevent or treat COVID-19.#